Balanced news tone
News Sentiment
OABI sentiment intelligence
OmniAb Inc. news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Price is moving more forcefully than the current news tone suggests.
77/100 classification confidence.
directly relevant articles
high-authority source matches
-5.4% over one week, +0.9% over four weeks, trend active, and below fair value.
OmniAb to Report Second Quarter 2026 Financial Results on August 6
Market Reaction
Price moving ahead of tone
Price is moving more forcefully than the current news tone suggests.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
OmniAb to Report Second Quarter 2026 Financial Results on August 6
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 16 Jul 2026 12:00
- Source
- Business Wire
Q1 Earnings Highs And Lows: Natera (NASDAQ:NTRA) Vs The Rest Of The Biotechnology Stocks
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 15 Jul 2026 07:00
- Source
- StockStory
OmniAb Names Amechi Nwachuku Chief Operating Officer
OmniAb, Inc. (NASDAQ:OABI) has appointed Amechi Nwachuku as its new Executive Vice President and Chief Operating Officer, effective immediately. Nwachuku brings over 25 years of experience in leading global life sciences tools businesses and will primarily manage the strategy and
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 14 Jul 2026 08:42
- Source
- Nasdaq
OmniAb appoints Amechi Nwachuku as chief operating officer
OmniAb, Inc. (NASDAQ:OABI) has appointed Amechi Nwachuku as Executive Vice President and Chief Operating Officer, a new role focused on strategy, operations, and commercial aspects of its xPloration platform. Nwachuku brings over 25 years of experience in life sciences and has he
- Tone
- Positive 72/100
- Event
- Market update
- Published
- 13 Jul 2026 20:44
- Source
- Investing.com
OmniAb, Inc. Appoints Amechi Nwachuku as Chief Operating Officer – Leadership Update July 2026
OmniAb, Inc. has filed a routine Form 8-K with the SEC on July 13, 2026, which does not contain any price-sensitive or material news. The filing updates standard company and security information but discloses no new operational, financial, strategic developments, or changes in di
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 13 Jul 2026 16:12
- Source
- Minichart
Omniab, Inc. Announces Appointment of Amechi Nwachuku to Executive Vice President and Chief Operating Officer, Effective July 13, 2026
OmniAb, Inc. has appointed Amechi Nwachuku as its new Executive Vice President and Chief Operating Officer, effective July 13, 2026. Nwachuku brings over two decades of global life sciences leadership experience from companies including Thermo Fisher Scientific, Danaher's SCIEX a
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 13 Jul 2026 15:12
- Source
- www.marketscreener.com
OmniAb Taps Amechi Nwachuku as Executive Vice President & Chief Operating Officer
OmniAb Inc. has appointed Amechi Nwachuku as its new Executive Vice President and Chief Operating Officer (COO). In this role, Nwachuku will be responsible for overseeing the strategy, operations, and commercial maximization of OmniAb’s xPloration platform. He brings over 25 year
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 13 Jul 2026 15:12
- Source
- Contract Pharma
OmniAb stock rises after naming new chief operating officer
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 13 Jul 2026 13:22
- Source
- Investing.com
OmniAb appoints Amechi Nwachuku as chief operating officer By Investing.com
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 13 Jul 2026 12:57
- Source
- Investing.com South Africa
Unpacking Q1 Earnings: Incyte (NASDAQ:INCY) In The Context Of Other Biotechnology Stocks
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 13 Jul 2026 12:30
- Source
- Market source
OmniAb Appoints Amechi Nwachuku COO to Expand xPloration Platform Commercialization
OmniAb Inc. (NASDAQ: OABI) has appointed Amechi Nwachuku as Executive Vice President and Chief Operating Officer to lead the strategy, operations, and commercial expansion of its xPloration® antibody discovery platform. Nwachuku brings over 25 years of experience in life sciences
- Tone
- Positive 74/100
- Event
- Market update
- Published
- 13 Jul 2026 13:12
- Source
- citybiz
Thermo Fisher veteran Amechi Nwachuku takes OmniAb COO role
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 13 Jul 2026 12:02
- Source
- Stock Titan
Amechi Nwachuku named COO at OmniAb with stock options and severance
OmniAb has appointed Amechi Nwachuku as Chief Operating Officer, effective July 13, 2026. His compensation package includes an initial annual base salary of $445,000, a target bonus of 45% of base salary, and a grant of options to purchase 800,000 shares. Nwachuku is also eligibl
- Tone
- Positive 63/100
- Event
- Analyst action
- Published
- 13 Jul 2026 12:12
- Source
- TradingView
OmniAb Inc. (OABI) Climbs 2.23% as Shares Approach Key Resistance at $2.40 - Strangle Setup
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 12 Jul 2026 17:38
- Source
- dars.gov.et
OABI,VKTX Revenue Breakdown
This article provides a financial overview and key performance indicators for two biotechnology companies: OmniAb Inc. (OABI) and Viking Therapeutics Inc. (VKTX). It details their market capitalization, income, sales, various financial ratios, stock performance, and analyst recom
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 07 Jul 2026 06:41
- Source
- Finviz
OmniAb (OABI) Price Target Decreased by 13.73% to 7.48
The article reports that the price target for OmniAb (OABI) has been decreased by 13.73%, bringing the new target to $7.48. This information solely focuses on the updated financial outlook for the company's stock.
- Tone
- Negative 28/100
- Event
- Guidance
- Published
- 05 Jul 2026 07:09
- Source
- MSN
OABI - OmniAb Inc Volatility & Greeks
This article provides a detailed financial overview of OmniAb Inc (OABI), including its stock performance metrics, volatility, and various financial ratios. It lists key data such as market capitalization, income, sales, and per-share values, alongside insider ownership, institut
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 04 Jul 2026 17:40
- Source
- Finviz
OmniAb (OABI) Gains More Than 38% Over 6 Months, Can It Go Higher?
OmniAb, Inc. (NASDAQ: OABI) has seen significant gains, rising over 38% in the past six months and 74% since its Q1 2026 earnings release. The company's revenue surged from $4.2 million to $14.4 million in Q1 2026, driven by milestone payments, while R&D and G&A costs decreased,
- Tone
- Positive 72/100
- Event
- Earnings
- Published
- 03 Jul 2026 09:13
- Source
- Insider Monkey
OmniAb, Inc. Warrant 2022- on Omniab Inc Financial Disclosures & SEC Filings
This article provides a comprehensive listing of OmniAb, Inc.'s financial disclosures and SEC filings, including quarterly and annual earnings reports, 8-Ks, 10-Qs, and 10-Ks. It details corporate events, investor updates, and press releases, offering insights into the company's
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 02 Jul 2026 09:39
- Source
- TradingView
OmniAb, Inc. Financial Disclosures & SEC Filings
This article provides a comprehensive list of OmniAb, Inc.'s financial disclosures and SEC filings, including earnings reports (Forms 10-K, 10-Q, 8-K), corporate presentations, and investor updates stretching from Q1 2026 back to Q4 2021. It details key highlights for each filing
- Tone
- Positive 64/100
- Event
- Earnings
- Published
- 01 Jul 2026 22:10
- Source
- TradingView
We're Not Very Worried About OmniAb's (NASDAQ:OABI) Cash Burn Rate
- Tone
- Neutral 50/100
- Event
- Balance sheet
- Published
- 30 Jun 2026 11:51
- Source
- simplywall.st
OmniAb, Inc.(NasdaqGM: OABI) dropped from Russell 2500 Growth Benchmark
OmniAb, Inc. (NasdaqGM: OABI) has been dropped from the Russell 2500 Growth Benchmark, a decision officially published on June 29, 2026. This exclusion is part of a broader removal from several Russell benchmarks, including the Russell Microcap Growth, Russell 2000 Growth, Russel
- Tone
- Negative 35/100
- Event
- Market update
- Published
- 29 Jun 2026 19:58
- Source
- marketscreener.com
Earnings Preview: OmniAb to Report Financial Results Post-market on May 07
OmniAb is scheduled to report its financial results after market close on May 07. This earnings preview indicates that investors and analysts will be closely watching the company's performance. The results will provide insight into the company's financial health and future outloo
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 29 Jun 2026 12:39
- Source
- Moomoo
OmniAb, Inc.(NasdaqGM: OABI) dropped from Russell 2000 Growth Benchmark
OmniAb, Inc. (NasdaqGM: OABI) has been removed from the Russell 2000 Growth Benchmark. This news follows earlier reports of its removal from the Russell Microcap Growth Benchmark Index and the Russell 3000E Growth Benchmark. OmniAb specializes in licensing discovery research tech
- Tone
- Negative 28/100
- Event
- Market update
- Published
- 29 Jun 2026 07:27
- Source
- www.marketscreener.com
OmniAb, Inc.(NasdaqGM: OABI) dropped from Russell 3000 Growth Benchmark
OmniAb, Inc. (NasdaqGM: OABI) has been dropped from the Russell 3000 Growth Benchmark. This move follows a series of similar announcements where the company was removed from other Russell indices, including the Russell 2500, Microcap, 2000, 3000E Growth, and Small Cap Comp Growth
- Tone
- Negative 28/100
- Event
- Market update
- Published
- 28 Jun 2026 18:11
- Source
- www.marketscreener.com
Enterprise value to revenue forward of OmniAb, Inc. – BOATS:OABIW
This article provides financial information for OmniAb, Inc. under the ticker OABIW, focusing on its enterprise value to revenue forward. It appears to be a financial data page from TradingView, offering an overview of the company's financials without detailed analysis. The conte
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 27 Jun 2026 19:39
- Source
- TradingView
OABI Forecast — Price Target — Prediction for 2027
This article provides a forecast and price target for OmniAb, Inc. (OABI) stock, including analyst opinions, historical price performance, and financial metrics. It highlights key data such as the current stock price, market capitalization, earnings reports, and volatility, while
- Tone
- Positive 62/100
- Event
- Analyst action
- Published
- 26 Jun 2026 01:41
- Source
- TradingView
Price to book forward of OmniAb, Inc. – BOATS:OABIW
This page provides financial information for OmniAb, Inc. (OABIW), specifically focusing on its price to book forward ratio. The data is presented through TradingView, noting that the market is currently closed with no trades.
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 26 Jun 2026 01:41
- Source
- TradingView
OmniAb, Inc. Actuals & Estimates (NASDAQ:OABI)
This article provides an overview of OmniAb, Inc. (NASDAQ: OABI) stock performance, financial actuals, and analyst estimates. It covers various metrics including current stock price, market capitalization, earnings, revenue, and future forecasts, offering insights into the compan
- Tone
- Positive 59/100
- Event
- Earnings
- Published
- 26 Jun 2026 00:40
- Source
- TradingView
Price to earnings forward of OmniAb, Inc. – BOATS:OABIW
This article provides financial information for OmniAb, Inc. under the ticker symbol OABIW on the Blue Ocean Alternative Trade System (BOATS). It specifically highlights the "Price to earnings forward" metric. The content appears to be a financial data page from TradingView, show
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 25 Jun 2026 17:39
- Source
- TradingView